Cargando…
Leukemia Cutis in Childhood Acute Myeloid Leukemia: Epidemiological, Clinical, Biological, and Prognostic Characteristics of Patients Included in the ELAM02 Study
Autores principales: | Gouache, Elodie, Greze, Victoria, Strullu, Marion, Saultier, Paul, Fenneteau, Odile, Gandemer, Virginie, Ragu, Christine, Auvrignon, Anne, Boutroux, Hélène, Lapillonne, Hélène, Pasquet, Marlène, Leverger, Guy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407794/ https://www.ncbi.nlm.nih.gov/pubmed/30887005 http://dx.doi.org/10.1097/HS9.0000000000000141 |
Ejemplares similares
-
Maintenance Therapy With Interleukin-2 for Childhood AML: Results of ELAM02 Phase III Randomized Trial
por: Petit, Arnaud, et al.
Publicado: (2018) -
Is Acute Myeloblastic Leukemia in Children Under 2 Years of Age a Specific Entity? A Report from the FRENCH ELAM02 Study Group
por: Blais, S., et al.
Publicado: (2019) -
Germline pathogenic variants in transcription factors predisposing to pediatric acute myeloid leukemia: results from the French ELAM02 trial
por: Fenwarth, Laurène, et al.
Publicado: (2020) -
Prognostic impact of RUNX1 mutations and deletions in pediatric acute myeloid leukemia: results from the French ELAM02 study group
por: Lew-Derivry, Lucille, et al.
Publicado: (2023) -
Molecular Profiling Defines Distinct Prognostic Subgroups in Childhood AML: A Report From the French ELAM02 Study Group
por: Marceau-Renaut, Alice, et al.
Publicado: (2018)